Adoption of hypofractionated radiotherapy (HyRT) for ductal carcinoma in situ (DCIS): A SEER-Medicare study.
Aaron David Falchook
No relevant relationships to disclose
Laura H. Hendrix
No relevant relationships to disclose
Noam Avraham VanderWalde
No relevant relationships to disclose
Timothy M. Zagar
No relevant relationships to disclose
Ellen Jones
No relevant relationships to disclose
Reshma Jagsi
Consultant or Advisory Role - Eviti
Research Funding - AbbVie
Ronald C. Chen
No relevant relationships to disclose